ADC Therapeutics SA (ADCT) Files Form 13G on April 24

ADC Therapeutics SA (ADCT) filed Form 13G on April 24. This document is typically filed by investors owning more than 5% of a company’s securities, indicating a significant stake. The filing reflects changes in beneficial ownership and is critical for transparency in market transactions. Monitoring such filings helps investors understand the shareholder dynamics that can influence stock performance.